Table 2.
Univariate and multivariate analyses for risk factors associated with mortality in different age groups of hypertensive women. Abbreviations represent: OR - odds ratio; CI - confidence interval; COPD - chronic obstructive pulmonary disease. Analyses include 7 subgroups, in which 6 are shown in the table; another one (≦49 y, n = 978, all P values <0.05) is not listed. Multivariate analysis is adjusted for the other factors in the table with significance (P < 0.05) in univariate analysis. Pneumonia and lung cancer are among significant risk factors from multivariate analyses (P < 0.05) in certain age groups.
| Analyses | 50–59 y, n = 2626 | 60–69 y, n = 3443 | 70–79 y, n = 4539 | 80–89 y, n = 2356 | ≧90 y, n = 273 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variables (Risk factors) | Univariate | Multivariate | Univariate | Multivariate | Univariate | Multivariate | Univariate | Multivariate | Univariate | Multivariate | |||||
| P | P | OR 95% CI | P | P | OR 95% CI | P | P | OR 95% CI | P | P | OR 95% CI | P | P | OR 95% CI | |
| Cardiovascular diseases | |||||||||||||||
| Coronary heart disease | >0.05 | >0.05 | 0.000 | 0000 | 2.38 | 0.000 | 00.000 | 2.19 | >0.05 | ||||||
| 1.75–3.23 | 1.62–2.98 | ||||||||||||||
| Metabolic diseases | |||||||||||||||
| Dyslipidemia | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | ||||||||||
| Diabetes | >0.05 | >0.05 | >0.05 | 0.053 | 00.038 | 1.40 | >0.05 | ||||||||
| 1.02–1.93 | |||||||||||||||
| Obesity | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | ||||||||||
| Cerebrovascular diseases | |||||||||||||||
| Cerebral infarction | >0.05 | >0.05 | >0.05 | 0.038 | 00.012 | 1.58 | >0.05 | ||||||||
| 1.11–2.25 | |||||||||||||||
| Cerebral hemorrhage (CH) | 0.000 | >0.05 | 0.002 | >0.05 | 0.000 | >0.05 | >0.05 | >0.05 | |||||||
| Acute CH | 0.000 | 0.000 | 46.44 | 0.004 | >0.05 | 0.000 | 0.038 | 6.10 | >0.05 | >0.05 | |||||
| 12. 53–172.13 | 1.10–33.50 | ||||||||||||||
| TIA (Transient ischemic attack) | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | ||||||||||
| Respiratory diseases | |||||||||||||||
| Tuberculosis | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | ||||||||||
| Pulmonary infection | |||||||||||||||
| Pneumonia | 0.000 | 0.000 | 22.58 | 0.000 | 0.000 | 7.17 | 0.000 | 0.000 | 4.72 | 0.000 | 0.000 | 6.40 | 0.000 | >0.05 | |
| 9.97–51.12 | 4.46–11.52 | 3.06–7.30 | 4.06–10.08 | ||||||||||||
| Trachea and bronchitis | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | ||||||||||
| COPD | >0.05 | 0.038 | 0.000 | >0.05 | 0.011 | >0.05 | |||||||||
| Digestive system diseases | |||||||||||||||
| Upper digestive tract diseases | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | ||||||||||
| Gastrointestinal hemorrhage | >0.05 | 0.001 | >0.05 | 0.000 | 0.008 | 3.30 | 0.000 | >0.05 | >0.05 | ||||||
| 1.37–7.94 | |||||||||||||||
| Gallbladder bile duct disease | >0.05 | >0.05 | >0.05 | 0.017 | >0.05 | >0.05 | |||||||||
| Tumors | 0.000 | 0.000 | 0.000 | 5.23 | 0.000 | 0.000 | 3.18 | 0.000 | 0.000 | 3.04 | 0.000 | ||||
| 3.23–8.44 | 2.20–4.58 | 1.99-.4.05 | |||||||||||||
| Breast cancers | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | ||||||||||
| Uterine cancer | >0.05 | >0.05 | >0.05 | >0.05 | >0.05 | ||||||||||
| Lung cancer | 0.050 | 0.000 | >0.05 | 0.000 | 0.001 | 2.55 | 0.000 | >0.05 | >0.05 | ||||||
| 1.45–4.49 | |||||||||||||||
| Inflammation and infection | 0.000 | >0.05 | 0.000 | >0.05 | 0.000 | >0.05 | 0.000 | >0.05 | 0.001 | 0.003 | 3.42 | ||||
| 1.50–7.78 | |||||||||||||||
| Acute diseases | 0.000 | >0.05 | 0.000 | 0.000 | 4.26 | 0.000 | 0.000 | 3.08 | 0.000 | 0.000 | 2.86 | >0.05 | |||
| 2.34–7.74 | 2.09–4.54 | 1.98–4.14 | |||||||||||||
| Chronic diseases | >0.05 | >0.05 | 0.000 | >0.05 | 0.000 | >0.05 | >0.05 | ||||||||
| Bleeding diseases | 0.000 | >0.05 | 0.000 | 0.000 | 7.98 | 0.000 | >0.05 | 0.000 | >0.05 | 0.000 | 0.000 | 3.51 | |||
| 3.67–17.34 | 1.22–10.08 | ||||||||||||||